Company Callitas Health Inc. Deutsche Boerse AG
Equities
T3F3
CA13125C1068
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Consumer Health and Wellness Products
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -5.46% |
Sales per region
CAD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -5.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 02/01/18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Joshua Maurice
SAM | Sales & Marketing | - | 31/08/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 30/11/14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,271,962 | 32,615,816 ( 72.04 %) | 0 | 72.04 % |
Company contact information
Callitas Health, Inc.
187 Pavilion Parkway Suite 200
41071, Newport
+859 868 3131
http://www.callitas.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+48.54% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |